Advisor ​/ Senior Advisor, CNS​/PNS NAMs - Investigative Toxicology

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve.

This is hard, urgent, selfless work-but it's work worth doing. If you're driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

** Position Overview*
* We are seeking a highly motivated and innovative scientist to join the New Approach Methodologies (NAMs)/Complex In Vitro Models (CIVMs) pillar within Lilly's Investigative Toxicology group. This individual contributor, primarily laboratory-based role sits within an integrated group where in vitro and in vivo safety science are united under a single leadership, enabling seamless translational science across the drug discovery continuum.

The successful candidate will serve as the primary scientific contributor to Lilly's CNS/PNS safety NAMs capability - designing, qualifying, and applying advanced human-relevant in vitro models to detect, characterize, and mechanistically understand compound-induced liabilities across the central nervous system (CNS), peripheral nervous system (PNS), and blood-brain barrier (BBB). Liabilities of primary interest include neurotoxicity (excitotoxicity, neuroinflammation, mitochondrial dysfunction), seizurogenic and network activity perturbation, demyelination, peripheral neuropathy/axonopathy, and BBB integrity disruption.

The role demands scientific depth in neural biology, a mechanistic attitude toward safety translation, and the drive to advance neuronal CIVM science both internally and externally.

** Key Responsibilities*
* + Develop, qualify, and apply advanced human-relevant in vitro models for CNS/PNS liability assessment, including iPSC-derived neurons and glial cells, co-culture systems, organoids/assembloids, dorsal root ganglion (DRG) neuron models, and BBB models to detect and characterize compound-induced neural injury across Lilly's portfolio.

+ Design and implement mechanistic investigations into compound-induced CNS/PNS liabilities including excitotoxicity, seizurogenic activity, demyelination, neuroinflammation, mitochondrial dysfunction, axonopathy, and BBB integrity disruption.

+ Implement functional MEAs and/or FLIPR calcium flux assays as primary liability readouts for seizurogenic potential, ion channel perturbation, and neural network activity disruption; qualify novel assays and endpoints that improve the sensitivity, specificity, throughput, and translational relevance of CNS/PNS liability screening.

+ Develop deep scientific expertise in CNS/PNS liability science and serve as a key scientific resource for project teams by designing/performing in vitro follow-on investigations to understand mechanism of toxicity and species translatability.

+ Collaborate with Lilly's in silico ADMET Intelligence group to integrate computational CNS/PNS liability predictions with in vitro mechanistic data, contributing to coherent and tiered safety decision frameworks for project teams.

+ Evaluate emerging technologies and recommend platforms for adoption that meaningfully strengthen the human relevance of Lilly's CNS/PNS safety science.

+ Independently review primary literature to generate mechanistic hypotheses and design in vitro studies to test them.

+ Serve as scientific point of contact for CRO and academic partners conducting CNS/PNS NAMs work on Lilly's behalf, overseeing study design, data quality, and deliverable standards.

+ Participate in pre-competitive consortia and industry working groups advancing CNS/PNS NAMs and early safety science.

+ Publish peer-reviewed research and present findings at national and international scientific meetings.

** Minimum Requirements*
* + PhD in Neuroscience, Neurotoxicology, Pharmacology, Biomedical Engineering, Cell Biology, or a closely related discipline.

+  
**…